Skip to main content

Table 2 Comparisons of demographic and clinical characteristics by gender in patients with epilepsy (n = 133)

From: Gender differences in prevalence and risk factors of sleep disturbances in patients with epilepsy

 

Total (n = 133)

Men (n = 68)

Women (n = 65)

p

Age (y)

30.2 ± 10.6

29.5 ± 10.7

31.0 ± 10.6

0.399

BMI (kg/m2)

22.0 ± 3.2

22.7 ± 3.4

21.2 ± 2.9

0.007

Age at seizure onset (y)

21.2 ± 11.8

21.7 ± 12.0

20.8 ± 11.7

0.644

Epilepsy duration (y)

9.0 ± 7.5

7.8 ± 7.2

10.4 ± 7.6

0.043

Nocturnal seizures (n, %)

40 (30.1)

20 (29.4)

20 (30.8)

0.865

Seizure types (n, %)

   

0.035

 Focal

82 (61.7)

36 (52.9)

46 (70.8)

 

 General

51 (38.3)

32 (47.1)

19 (29.2)

 

AEDs (n, %)

   

0.902

 Drug free

20 (15.2)

11 (16.4)

9 (13.8)

 

 AED monotherapy

47 (35.6)

24 (35.8)

23 (35.4)

 

 AED polytherapy

65 (49.2)

32 (47.8)

33 (50.8)

 

Seizure frequency (n, %)

   

0.415

 Seizure free

29 (21.8)

17 (25.0)

12 (18.5)

 

 < 1 seizure/m

40 (30.1)

22 (32.4)

18 (27.7)

 

 ≥1 seizure/m

64 (48.1)

29 (42.6)

35 (53.8)

 

ISI

7.6 ± 5.8

7.5 ± 5.7

7.8 ± 6.0

0.772

Moderate to severe clinical insomnia (ISI > 14)

27 (20.5)

14 (20.6)

13 (20.3)

0.969

PSQI

5.2 ± 3.0

4.9 ± 2.7

5.6 ± 3.2

0.256

Poor sleep quality (PSQI> 5)

53 (40.2)

24 (35.3)

29 (45.3)

0.241

BDI

10.5 ± 8.9

10.7 ± 9.8

10.2 ± 8.0

0.778

BAI

30.2 ± 8.5

29.8 ± 8.9

30.6 ± 8.1

0.292

  1. Data are presented as counts (%) or mean ± SD
  2. The p-values are obtained from independent-sample t-test, the chi-square test and Mann-Whitney U test
  3. BMI body mass index, AED antiepileptic drug, ISI Insomnia Severity Index, PSQI Pittsburgh Sleep Quality Index, BDI Beck Depression Inventory, BAI Beck Anxiety Inventory